A new trading day began on Monday, with Spruce Biosciences Inc (NASDAQ: SPRB) stock price up 7.88% from the previous day of trading, before settling in for the closing price of $0.50. SPRB’s price has ranged from $0.41 to $5.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 24.80%. With a float of $27.36 million, this company’s outstanding shares have now reached $41.30 million.
In an organization with 29 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -14.36%, operating margin of -608.94%, and the pretax margin is -555.23%.
Spruce Biosciences Inc (SPRB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Spruce Biosciences Inc is 33.75%, while institutional ownership is 22.15%. The most recent insider transaction that took place on Mar 21 ’24, was worth 350,951. In this transaction 10% Owner of this company sold 465,021 shares at a rate of $0.75, taking the stock ownership to the 2,550,000 shares. Before that another transaction happened on Mar 18 ’24, when Company’s 10% Owner sold 842,020 for $0.77, making the entire transaction worth $647,008. This insider now owns 3,968,000 shares in total.
Spruce Biosciences Inc (SPRB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.80% per share during the next fiscal year.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
Here are Spruce Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.91 in one year’s time.
Technical Analysis of Spruce Biosciences Inc (SPRB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.33 million. That was inferior than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 28.18%. Additionally, its Average True Range was 0.04.
During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 65.04%, which indicates a significant decrease from 66.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.62% in the past 14 days, which was higher than the 50.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5115, while its 200-day Moving Average is $0.8854. However, in the short run, Spruce Biosciences Inc’s stock first resistance to watch stands at $0.5603. Second resistance stands at $0.5813. The third major resistance level sits at $0.6150. If the price goes on to break the first support level at $0.5056, it is likely to go to the next support level at $0.4719. Assuming the price breaks the second support level, the third support level stands at $0.4509.
Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats
With a market capitalization of 22.27 million, the company has a total of 41,303K Shares Outstanding. Currently, annual sales are 10,090 K while annual income is -47,920 K. The company’s previous quarter sales were 600 K while its latest quarter income was -8,670 K.
